Biotech Drug Pilot Plant To Be Established To Cut Imports

News: Thailand's King Mongkut's University of Technology Thonburi (KMUTT) and the National Science and Technology Development Agency (NSTDA) have partnered to build a national biotechnology drug pilot plant, a move that aims to improve the domestic manufacturing of drugs and vaccines. The move is expected to cut imports and reduce reliance on imported biotechnology drugs. The pilot project aims to expand the size of the production process at both the prototype and industrial levels for commercial purposes, which will allow the Thai population to access cheap qualitative biotechnology drugs . The facility is also expected to be used as a training centre for development work in the production process, especially quality control.

This article is tagged to:
Related sectors of this article: Pharmaceuticals & Healthcare, Industry Data - Pharmaceuticals, Biotechnology
Geography: Thailand

Enter your details to read the full article

By submitting this form you are acknowledging that you have read and understood our Privacy Policy.